Inhibition of lipopolysaccharide-induced bowel erythrocyte extravasation in rats, and of mesenteric hypoperfusion in dogs, by phosphodiesterase inhibitors

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 153-159

  Cardelús, Ignasi ^a   Gras, Jordi ^a   Jáuregui, José ^a   Llenas, Jesús ^a   Palacios, José María ^a  

^a Research Center ^*  (Spain)

Author keywords

Intestinal erythrocyte extravasation; Lipopolysaccharide; Phosphodiesterase inhibitor

Indexed keywords

DENBUFYLLINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ERYTHROCYTE; EXTRAVASATION; HEART INDEX; HISTOLOGY; INTESTINE ISCHEMIA; INTESTINE NECROSIS; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; LIVER; LUNG; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTECTION; RAT; SEPTIC SHOCK;

EID: 0029928449     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00817-9     Document Type: Article

References (41)

1. Balis, J.U., E.S. Rappaport, L. Gerber, J. Fareed, F. Buddingh and H.L. Messmore, 1978, A primate model for prolonged endotoxin shock. Blood-vascular reactions and effects of glucocorticoid treatment, Lab. Invest. 38, 511.
2. Benjamin, E. and T. Iberti, 1991, Mesenteric ischemia and sepsis, in: Vascular Anesthesia, ed. J.A. Kaplan (Churchill & Livingstone, New York) p. 417.
3. Benjamin, E., J.M. Oropello and T.J. Iberti, 1993, Acute mesenteric ischemia: pathophysiology, diagnosis, and treatment, Disease Month 34, 131.
4. Brackett, D.J., C.F. Schaefer, P. Tompkins, L. Fagraeus, L.J. Peters and M.F. Wilson, 1985, Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia, Circ. Shock 17, 273.
5. Bulkley, G.B., P.R. Kvietys, D.A. Parks, M.A. Perry and D.N. Granger, 1985, Relationship of blood flow and oxygen consumption to ischemic injury in the canine small intestine, Gastroenterology 89, 852.
6. Caplan, M.S., X. Sun and W. Huseuh, 1990, Hypoxia causes ischemic bowel necrosis in rats: the role of platelet activating factor (PAF-acether), Gastroenterology 99, 979.
7. Caplan, M.S., A. Kelly and W. Hsueh, 1992, Endotoxin and hypoxia-induced intestinal necrosis in rats. The role of platelet activating factor, Pediatr. Res. 31(5), 428.
8. Fink, M.P., 1993, Adequacy of gut oxygenation in endotoxemia and sepsis, Crit. Care Med. 21(2), S4.
9. Firestein, G., D. Boyle, D. Bullough, H. Gruber, F. Sajjadi, A. Montag, B. Sambol and K. Mullane, 1994, Protective effect of an adenosine kinase inhibitor in septic shock, J. Immunol. 152, 5853.
10. Fischer, W., C. Schudt and A. Wendel, 1993, Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice, Biochem. Pharmacol. 45(12), 2399.
11. Fretschner, R., T. Kloss and U. Birkenhauer, 1992, Amrinone for cardiovascular therapy in hypodynamic septic patients?, Anesthesiol. Intensivmed. Notfallmed, Schmerzther. 27(3), 166.
12. Fry, D.E., L. Pearlstein, R.L. Fulton and H.C. Polk, 1980, Multiple system organ failure:The role of uncontrolled infection, Arch. Surg. 115, 136.
13. Gibson, R.L., G.J. Redding, W.R. Henderson, W.E. Truog and B. Group, 1991, Streptococcus induces tumor necrosis factor in neonatal piglets, Am. Rev. Respir. Dis. 143, 598.
14. Giroir, B.P. and B. Beutler, 1992, Effect of amrinone on tumor necrosis factor production in endotoxic shock, Circ. Shock 36, 200.
15. Hewett, J.A. and R.A. Roth, 1993, Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides, Pharmacol. Rev. 45(4), 381.
16. Ishizaka, A., Z. Wu, K. Stephens, H. Harada, R. Hogue, P. O'hanley and R. Raffin, 1988, Attenuation of acute lung injury in septic guinea pigs by pentoxifylline, Am. Rev. Respir. Dis. 138, 376.
17. László, F., B.J.R. Whittle and S. Moncada, 1994, Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors, Br. J. Pharmacol. 111, 1309.
18. Nicholson, C.D., S.A. Jackman and R. Wilke, 1989, The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site, Br. J. Pharmacol. 97, 889.
19. Noel, P., S. Nelson, R. Bokulic, G. Bagby, H. Lippton, G. Lipscomb and W. Summer, 1990, Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis fatcor and mortality, Life Sci. 47, 1023.
20. Novogrodsky, A., A. Vanichkin, M. Patya, A. Gazit, N. Osherov and A. Levitzki, 1994, Prevention of lipopolysaccharide induced lethal toxicity by tyrosine kinase inhibitors, Science 264, 1319.
21. Ochalski, S.J., D.A. Hartman, M.T. Belfast, T.L. Walter, K.B. Glasser and R.P. Carlson, 1993, Inhibition of endotoxin-induced hypothermia and serum TNF-alpha levels in CD-1 mice by various pharmacological agents, Agents Actions 39, C52.
22. Parrillo, J.E., 1993, Pathogenic mechanisms of septic shock, New Engl. J. Med. 328(20), 1471.
23. Pellón, M.I., A.A. Steil, V. Furió and M. Sanchez-Crespo, 1994, Study of the effector mechanism involved in the production of hemorrhagic necrosis of the small intestine in rat passive anaphylaxis, Br. J. Pharmacol. 112, 1101.
24. Rice, G.C., P.A. Brown, R.J. Nelson, J.A. Bianco, J.W. Songer and S. Bursten, 1994, Protection from endotoxic shock in mice by pharmacological inhibition of phosphatidic acid, Proc. Natl. Acad. Sci. USA 91, 3857.
25. Robinson, J.W.L. and J.A. Antonioli, 1966, The intestinal response to ischemia, Naunyn-Schmied. Arch. Pharmacol. 255, 178.
26. Rola-Pleszczynski, M., M. Thivierge, S. Ouellet and P. Dagenais, 1994, Cytokines and eicosanoids regulate PAF receptor gene expression, IXth International Conference on Prostaglandins and Related Compounds, Florence (Italy) P55.
27. Schade, U., 1990, Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor, Circ. Res. 31, 171.
28. Schade, U. and P. Zabel, 1994, Modulating effects of pentoxifylline on cytokine release syndromes, in: Sepsis, eds. K. Reinhart, K. Eyrich and C. Spung (Springer-Verlag, Berlin) p. 371.
29. Schade, F.U., M. Ernst, M. Reinke and D.T. Wolter, 1994, Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo, Biochem. Biophys. Res. Commun. 159, 748.
30. Schönharting, M. and U. Schade, 1989, The effect of pentoxifylline in septic shock. New pharmacologic aspects of an established drug, J. Med. 20(1), 97.
31. Sibbons, P.D. and L. Spitz, 1992, Necrotizing enterocolitis induced by local circulatory interruption in the ileum of neonatal piglets, Pediatr. Pathol. 12, 1.
32. Strieter, R.M., D.G. Remik, P.A. Ward, R.N. Sprengler, J.P. Lynch, J. Larrick and S.L. Kunkel, 1988, Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifytline, Biochem. Biophys. Res. Commun. 155(3), 1230.
33. Tavares de Lima, W., P. Sirois and S. Jancar, 1992, Inmunocomplex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions, Eur. J. Pharmacol. 213, 63.
34. Temple, G.E., J.A Cook, W.C. Wise, P.V. Halushka and D. Corral, 1986, Improvement in organ blood flow by inhibition of tromboxane synthetase during experimental endotoxic shock in the rat, J. Cardiovasc. Pharmacol. 8, 514.
35. Turner, C.R., K.M. Esser and E.B. Wheeldon, 1993, Therapeutic intervention in a rat model of ADRS: phosphodieterase IV inhibition, Circ. Shock 39, 237.
36. Vincent, J.L., M. Domb, P. Van der Linden, S. Motte, C.D. Boelpaepe, B. Contempré and F. Cantraine, 1988, Amrinone administration in endotoxic shock, Circ. Shock 25, 75.
37. Wallace, J.L., G. Cirino, G. Webb McKnight and S.N. Elliot, 1995, Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester, Eur. J. Pharmacol. 280, 63.
38. Ward, A. and S.P. Clissold, 1987, Pentoxifylline. A review of its pharmacodynamic and pharmacokynetic properties, and its therapeutic efficacy, Drugs 34, 50.
39. Waxman, K., 1990, Pentoxifylline in septic shock, Crit. Care Med. 18, 243.
40. Whitworth, P.W., H.M. Cryer, R.N. Garrison, T.E. Baumgarten and P.D. Harris, 1989, Hypoperfusion of the intestinal microcirculation without decreased cardiac output during live Escherichia coli sepsis in rats, Circ. Shock 27, 111.
41. Xiamong, S., M. Caplan, L. Yueying and W. Hsueh, 1995, Endotoxin-resistant mice are protected from PAF-induced bowel injury and death. Role of TNF, Complement Activation, and Endogenous PAF production, Dig. Dis. Sci. 40(3), 495.